This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Jan. 8, 2013


 Area and Association News

DEA: Disposal of controlled substances
Office of Diversion Control    Share    Share on FacebookTwitterShare on LinkedinE-mail article
This rule proposes requirements to govern the secure disposal of controlled substances by both DEA registrants and ultimate users. These regulations would implement the Secure and Responsible Drug Disposal Act of 2010 by expanding the options available to collect controlled substances from ultimate users for purposes of disposal to include: take-back events, mail-back programs and collection receptacle locations. These proposed regulations contain specific language to continue to allow law enforcement agencies to voluntarily conduct take-back events, administer mail-back programs, and maintain collection receptacles. These regulations propose to allow authorized manufacturers, distributors, reverse distributors and retail pharmacies to voluntarily administer mail-back programs and maintain collection receptacles. In addition, this proposed rule expands the authority of authorized retail pharmacies to voluntarily maintain collection receptacles at long term care facilities. This proposed rule also reorganizes and consolidates existing regulations on disposal, including the role of reverse distributors. More

How to be healthy
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A holiday message from Dr. Karen Lewis, medical director, Arizona Immunization Program Office, Arizona Department of Health Services:

Doctors want you to be healthy.
In everything you do.
So please remember the flu shot.
And keep away the flu.

Be healthy. Stay healthy.
Doctors want you to stay healthy.
A flu shot. A flu shot.
Flu shots will help you stay well.

Sign the petition!
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Pharmacists as Providers — we need 25,000 signatures by Jan. 26. Learn more.

Inaugural Southwest Pharmacy Symposium
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Become a Pharmacy A.C.E. — Advocate, Communicate, Educate. Saturday, Jan. 26, 2013. Learn more.

Not an AzPA member? Join today
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Not an AzPA member? Join the only statewide association representing all pharmacy professionals in all pharmacy practice settings. With over 1,500 members, we are a leading association of pharmacists spreading the news and events of our industry. More

 Pharmacy Updates

Color of generic drugs impacts medication compliance
PsychCentral    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The fact that generic drugs are often a different color and/or shape from brand name medications appears to reduce medication compliance, according to a new study. In an effort to control healthcare costs, use of generic medications is frequently encouraged or mandated. Generics currently account for more than 70 percent of prescriptions dispensed. More

'Fiscal cliff' deal has consequences for pharmacies
Pharmacy Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
After several months of negotiations among legislators and the White House, both houses of the United States Congress have passed a bill to dampen the effects of the "fiscal cliff," a combination of spending cuts and tax increases that were set to go into effect at the beginning of 2013. The bill, which President Barack Obama is expected to sign into law, will affect the majority of Americans, but several of its elements will have specific consequences for community pharmacies. More

Pharmacy says cleaners should share blame for meningitis outbreak
CNN    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A Massachusetts pharmacy linked to a meningitis outbreak says its cleaning contractor should share blame for the apparent mishap that left dozens dead nationwide. The New England Compounding Center sent a letter to UniFirst Corp. demanding it share responsibility for a tainted steroid used to treat pain and inflammation, according to a recent filing with the Securities and Exchange Commission. MORE

Related article:
  • Massachusetts plans stricter control of compounding pharmacies (The New York Times)

  •  In the News

    Revamped adherence strategies could help reduce revenue loss
    Pharmacy Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    Nonadherence to medication for chronic conditions results in an estimated $188 billion revenue loss per year for the pharmaceutical industry, according to a report produced by Capgemini Consulting and HealthPrize Technologies. The loss amounts to 59 percent of total pharmaceutical revenue in the United States and can be extrapolated to an estimated loss of $564 billion in global pharmaceutical revenues. More

    Patient adherence goals drive Wal-Mart's new compliance pack launch
    Packaging World    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    A recognized leader in retail trends and sustainability issues, Wal-Mart is poised to further drive the use of patient-compliant calendarized packaging in the U.S. with its December 2012 launch of paperboard-based ecoslide-RX packs supplied by Keystone Folding Box Co. The new portable, calendar-style prescription packs, which aim to increase patient adherence to drug regimens, are now rolling out at nearly 4,600 Wal-Mart retail pharmacies across the U.S., initially for 40 different items, with plans to use the packs for another 35 to 40 items by early 2013. More

     Medication Updates

    Bedaquiline approved for multidrug-resistant TB
    American Society of Health-System Pharmacists    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    FDA and Janssen Therapeutics recently announced the approval of bedaquiline for the treatment of multidrug-resistant pulmonary tuberculosis. Janssen will market bedaquiline as Sirturo. A company spokeswoman said Janssen expects bedaquiline to be commercially available in the second quarter. More

    Dexpramipexole fails in ALS
    Medscape    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    Biogen Idec reports that topline results of a phase 3 trial investigating dexpramipexole in patients with amyotrophic lateral sclerosis failed to show a benefit on primary or secondary outcomes. "Based on these results, Biogen Idec will discontinue development of dexpramipexole in ALS," a statement from the company said. More

    Tamiflu approval expanded to include infants under age 1
    HealthDay News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    The Food and Drug Administration has expanded its approval of Tamiflu to include children as young as 2 weeks old who have shown symptoms of flu for two days or fewer, the agency recently said. Tamiflu was first approved in 1999 for adults who showed symptoms of flu for no longer than two days. It was since approved to prevent flu in people aged 1 year and older. More

    Apixaban approved for clot-risk reduction in nonvalvular atrial fibrillation
    American Society of Health-System Pharmacists    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    The FDA on Dec. 28 approved apixaban oral tablets to reduce the risk of stroke and systemic embolism in patients with nonvavular atrial fibrillation. The factor Xa inhibitor will be marketed as Eliquis by Bristol-Myers Squibb. The company expects the product to be widely available by the end of January. More

     Management & Marketing

    Insubordination: How to handle it legally
    Business Management Daily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    Insubordination can result when difficult employees intentionally disregard a direct order from a manager, or inadvertently cross the discipline line when company policy is involved. Knowing how to handle employee insubordination can go a long way toward avoiding legal consequences when discipline or discharge is necessary. If termination does become necessary, make sure you have documented employee reviews in case you need to show them in court. More

    How to build your employees' leadership skills
    Business News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    What are you going to do to make your company better in 2013? Shooting for financial targets is hardly enough. Chasing financial goals is futile if the company lacks the human talent necessary to achieve such goals. In brief, making any company better depends on how leaders retain and leverage their human assets as a distinctive competitive advantage. More


    AzPA Pharmacy Flash
    Colby Horton, Vice President of Publishing, 469.420.2601
    Download media kit

    Danielle Wegert, Content Editor, 469.420.2696   
    Contribute news

    Disclaimer: The AzPA Pharmacy Flash is a weekly roundup of articles of interest to pharmacists and pharmacy professionals. This email may contain an advertisement of AzPA and/or third party products and services. Opinions expressed in these articles do not necessarily reflect the views of AzPA or its advertising partners. The AzPA Pharmacy Flash is compiled by MultiBriefs, a division of MultiView, Inc. Factual errors are the responsibility of the listed publication.

    This edition of the AzPA Pharmacy Flash was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
    Recent issues
    Jan. 8, 2013
    Jan. 1, 2013
    Dec. 25, 2012
    Dec. 18, 2012

    7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063